XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 46.11

Change

+0.67 (+1.47)%

Market Cap

CAD 0.55B

Volume

8.62K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-17 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

+2.32 (+1.53%)

CAD 20.69B
ZSP:CA BMO S&P 500

+1.39 (+1.49%)

CAD 18.86B
XSP:CA iShares Core S&P 500 (CAD Hedg..

+0.59 (+0.96%)

CAD 11.36B
VUN:CA Vanguard US Total Market

+1.65 (+1.44%)

CAD 11.07B
XUS:CA iShares Core S&P 500 Index ETF

+0.79 (+1.49%)

CAD 8.43B
HXS:CA Global X S&P 500 Corporate Cla..

+1.33 (+1.52%)

CAD 4.68B
VSP:CA Vanguard S&P 500 CAD hedged

+0.97 (+1.01%)

CAD 4.03B
QUU:CA Mackenzie US Large Cap Equity ..

+3.60 (+1.46%)

CAD 3.48B
XUU:CA iShares Core S&P US Total Mark..

+0.89 (+1.41%)

CAD 3.43B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

+0.84 (+1.59%)

CAD 3.26B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.67% 69% C- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.67% 69% C- 71% C-
Trailing 12 Months  
Capital Gain 33.54% 92% A 85% B
Dividend Return 1.07% 28% F 12% F
Total Return 34.61% 86% B+ 83% B
Trailing 5 Years  
Capital Gain 98.49% 79% B- 86% B+
Dividend Return 6.72% 15% F 12% F
Total Return 105.21% 75% C 85% B
Average Annual (5 Year Horizon)  
Capital Gain 15.02% 76% C+ 79% B-
Dividend Return 15.88% 73% C 76% C+
Total Return 0.85% 23% F 38% F
Risk Return Profile  
Volatility (Standard Deviation) 15.54% 37% F 55% F
Risk Adjusted Return 102.15% 64% D 95% A
Market Capitalization 0.55B 53% F 60% D-

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.